Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification [0.03%]
胃肠间质瘤：历史、分子亚型和风险分层
In Hye Song,Soomin Ahn,Hyung-Don Kim et al.
In Hye Song et al.
The gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors of the gastrointestinal tract. Between the 1990s and early 2000s, GIST was identified as a tumor characterized by KIT or PDGFRA mutations, resulting in i...
Biological Characteristics and Therapeutic Strategies for Resectable Locally Advanced Esophagogastric Junction Cancer: A Comprehensive Update [0.03%]
可切除的局部晚期食管胃结合部癌的生物学特征和治疗策略：全面更新
Koki Fujiwara,Satoru Matsuda,Yosuke Morimoto et al.
Koki Fujiwara et al.
Although the clinical importance of esophagogastric junction (EGJ) cancer is being increasingly recognized, its definition and treatment strategies vary considerably across regions. Recently, new concepts such as the gastroesophageal juncti...
Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of Helicobacter and Upper Gastrointestinal Research (KCHUGR) 2023 Survey [0.03%]
韩国全国早期胃癌内镜粘膜下挖除术调查：来自韩国幽门螺杆菌与上消化道研究协会（KCHUGR）2023年调查的结果
Jae Yong Park,Jeong Hoon Lee,Tae-Se Kim et al.
Jae Yong Park et al.
Purpose: Endoscopic submucosal dissection (ESD) has become a standard minimally invasive treatment for selected patients with early gastric cancer (EGC). This study presents the first nationwide survey of patients with EG...
From Control to Conversion: Optimizing Systemic Therapy for Curative-Intent Conversion Surgery in Metastatic Gastric Cancer [0.03%]
从控制到转化：优化系统性治疗以进行具有治愈意图的转化手术以治疗转移性胃癌
Hye Sook Han,Sun Young Rha
Hye Sook Han
Conversion therapy enables curative-intent resection in patients with initially unresectable or metastatic cancers after effective systemic therapy. Recently, advances in systemic therapy with molecular targeted agents and immune checkpoint...
CLDN18.2 in Gastric Cancer: Current Therapeutic Landscape and Future Perspectives [0.03%]
胃癌中的CLDN18.2：当前治疗格局与未来展望
Fei Zhang,Ukyo Okazaki,Izuma Nakayama et al.
Fei Zhang et al.
Claudin 18.2 (CLDN18.2), a tight junction protein selectively expressed in normal gastric epithelium and widely retained during carcinogenesis, has emerged as a promising therapeutic target for advanced gastric cancer (AGC). SPOTLIGHT and G...
Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence [0.03%]
胃癌新辅助化疗：日趋成熟的策略与循证医学证据
Young Jae Kim,Hyung-Don Kim,Jaewon Hyung et al.
Young Jae Kim et al.
Neoadjuvant and perioperative therapy have emerged as promising strategies for managing locally advanced gastric cancer (LAGC). Landmark phase III studies, such as PRODIGY and RESOLVE, have established neoadjuvant chemotherapy as a viable t...
Perioperative Nutritional Treatment for Patients With Gastric Cancer: Focusing on Recent Controversial Issues [0.03%]
胃癌围手术期营养治疗的现状与争议展望
Dongwoo Shin
Dongwoo Shin
Despite the many advances in treatment methods for gastric cancer, it remains a leading cause of cancer-related mortality worldwide, with treatment outcomes intrinsically linked to the nutritional status of the patient. Malnutrition is a fr...
Recent Advances in Endoscopic Submucosal Dissection for Gastric Cancer: Focusing on Expanded Indications and Technological Innovations [0.03%]
内镜黏膜下挖除术治疗胃癌的新进展：注重扩大适应证和技术创新
Waku Hatta,Yohei Ogata,Koya Ogasawara et al.
Waku Hatta et al.
The indications for endoscopic resection (ER) and the criteria for the curability of early gastric cancer (EGC) have been expanding. Among Korea, Japan, and Europe, Korea has the most strictly defined indication for ER, followed by Europe a...